600+ sources. One page. See who else covered it.
Novo Nordisk Chief Executive Officer Mike Doustdar says the profitability of its popular Wegovy weight-loss pill is "decent" and will continue to improve. "If that was not the case, we would not be launching the product in more and more markets," he tells Bloomberg Television. (Source: Bloomberg)
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
The road to Rotterdam runs through Phoenix. Get the full 2026 U.S. Gymnastics Championships schedule, streaming information and the stories to follow across four days of competition.
“He has never been particularly generous or nurturing.”
India is not considering an early closure of a program aimed at attracting deposits from the country’s 35-million-strong diaspora, with the central bank expecting robust inflows until the window shuts…
Nordea’s Chief Analyst Jan Størup Nielsen notes that Nationalbanken did not intervene in July to support Denmark’s fixed exchange rate policy, after a small purchase of kroner in June.
Don’t Quit Ventures fund has three unicorns among 17 bets and has already returned cash to LPs.
ESPOO, Finland — Tecnotree, a global leader in AI-native Digital Business Support Systems (BSS) and digital platform solutions for the telecommunications industry, today announced its financial…